Mucormycosis In Covid-19 Pandemic

Authors

  • Chandni Malhotra Junior Resident, Department of Obstrectics and Gynaecology, Government Medical College, Jammu, Jammu and Kashmir, India
  • Sachi Gupta Intern, Department of Ophthalmology, ASCOMS Jammu, Jammu and Kashmir, India
  • Sachit Mahajan Senior Resident, Department of Ophthalmology, Government Medical College, Jammu, Jammu and Kashmir, India
  • Satish Kumar Gupta Professor and Head, Department of Ophthalmology, Government Medical College, Jammu, Jammu and Kashmir, India

Keywords:

Mucormycosis, Uncontrolled Diabetes, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Abstract

Mucormycosis (Zygomycosis) is an invasive fungal infection. It typically affects immune compromised individuals with an impaired neutrophilic response. There are several case reports of Rhino-orbital-cerebral mucormycosis (ROCM) from all over the world. Recently, its alarming rise in the number amongCOVID-19 patients mostly with uncontrolled diabetes and those who received excessive administration ofsteroids for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection hasraised interest among the scientific community to learn more about the said disease. The current reviewdescribes, its epidemiology, clinical presentation, risk factors, warning signs, diagnostic test and available preventive and treatment modalities for its effective management.

Downloads

Published

2022-01-17

How to Cite

Chandni Malhotra, Sachi Gupta, Sachit Mahajan, & Satish Kumar Gupta. (2022). Mucormycosis In Covid-19 Pandemic. International Journal of Health and Clinical Research, 5(2), 208–211. Retrieved from https://ijhcr.com/index.php/ijhcr/article/view/4089

Similar Articles

You may also start an advanced similarity search for this article.